These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 35902787)

  • 21. Early introduction, dispersal and evolution of Delta SARS-CoV-2 in Southern Brazil, late predominance of AY.99.2 and AY.101 related lineages.
    Gularte JS; da Silva MS; Mosena ACS; Demoliner M; Hansen AW; Filippi M; Pereira VMAG; Heldt FH; Weber MN; de Almeida PR; Hoffmann AT; Valim ARM; Possuelo LG; Fleck JD; Spilki FR
    Virus Res; 2022 Apr; 311():198702. PubMed ID: 35104582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SARS-COV-2 genomic monitoring in the state of São Paulo unveils two emerging AY.43 sublineages.
    Lima ARJ; Ribeiro G; Viala VL; de Lima LPO; Martins AJ; Barros CRDS; Marqueze EC; Bernardino JST; Moretti DB; Rodrigues ES; Santos EV; Brassaloti RA; Cassano RLRC; Mariani PDSC; Clemente LG; Assato PA; Costa FADSD; Poleti MD; Lesbon JCC; Mattos EC; Banho CA; Sacchetto L; Moraes MM; Palmieri M; Martininghi M; Caldeira LAV; Silva FEVD; Grotto RMT; Souza-Neto JA; Giovanetti M; Junior Alcantara LC; Nogueira ML; Fukumasu H; Coutinho LL; Kashima S; Neto RM; Covas DT; Slavov SN; Sampaio SC; Elias MC
    J Med Virol; 2022 Jul; 94(7):3394-3398. PubMed ID: 35229308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sequence analysis of the emerging SARS-CoV-2 variant Omicron in South Africa.
    Wang L; Cheng G
    J Med Virol; 2022 Apr; 94(4):1728-1733. PubMed ID: 34897752
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic diversity of SARS-CoV-2 infections in Ghana from 2020-2021.
    Morang'a CM; Ngoi JM; Gyamfi J; Amuzu DSY; Nuertey BD; Soglo PM; Appiah V; Asante IA; Owusu-Oduro P; Armoo S; Adu-Gyasi D; Amoako N; Oliver-Commey J; Owusu M; Sylverken A; Fenteng ED; M'cormack VV; Tei-Maya F; Quansah EB; Ayivor-Djanie R; Amoako EK; Ogbe IT; Yemi BK; Osei-Wusu I; Mettle DNA; Saiid S; Tapela K; Dzabeng F; Magnussen V; Quaye J; Opurum PC; Carr RA; Ababio PT; Abass AK; Akoriyea SK; Amoako E; Kumi-Ansah F; Boakye OD; Mibut DK; Odoom T; Ofori-Boadu L; Allegye-Cudjoe E; Dassah S; Asoala V; Asante KP; Phillips RO; Osei-Atweneboana MY; Gyapong JO; Kuma-Aboagye P; Ampofo WK; Duedu KO; Ndam NT; Bediako Y; Quashie PK; Amenga-Etego LN; Awandare GA
    Nat Commun; 2022 May; 13(1):2494. PubMed ID: 35523782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emergency SARS-CoV-2 Variants of Concern: Novel Multiplex Real-Time RT-PCR Assay for Rapid Detection and Surveillance.
    Chung HY; Jian MJ; Chang CK; Lin JC; Yeh KM; Chen CW; Hsieh SS; Hung KS; Tang SH; Perng CL; Chang FY; Wang CH; Shang HS
    Microbiol Spectr; 2022 Feb; 10(1):e0251321. PubMed ID: 35196812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of SARS-CoV-2 different variants and related morbidity and mortality: a systematic review.
    SeyedAlinaghi S; Mirzapour P; Dadras O; Pashaei Z; Karimi A; MohsseniPour M; Soleymanzadeh M; Barzegary A; Afsahi AM; Vahedi F; Shamsabadi A; Behnezhad F; Saeidi S; Mehraeen E; Shayesteh Jahanfar
    Eur J Med Res; 2021 Jun; 26(1):51. PubMed ID: 34103090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spatial growth rate of emerging SARS-CoV-2 lineages in England, September 2020-December 2021.
    Smallman-Raynor MR; Cliff AD;
    Epidemiol Infect; 2022 Jul; 150():e145. PubMed ID: 35855577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Missense mutations in spike protein of SARS-CoV-2 delta variant contribute to the alteration in viral structure and interaction with hACE2 receptor.
    Mahmood TB; Hossan MI; Mahmud S; Shimu MSS; Alam MJ; Bhuyan MMR; Emran TB
    Immun Inflamm Dis; 2022 Sep; 10(9):e683. PubMed ID: 36039645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Haplotype distribution of SARS-CoV-2 variants in low and high vaccination rate countries during ongoing global COVID-19 pandemic in early 2021.
    Bui NN; Lin YT; Huang SH; Lin CW
    Infect Genet Evol; 2022 Jan; 97():105164. PubMed ID: 34848355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influence of new SARS-CoV-2 variant Omicron (B.1.1.529) on vaccine efficacy, its correlation to Delta variants: A computational approach.
    Ranjan P; Neha ; Devi C; Devar KA; Das P
    Microb Pathog; 2022 Aug; 169():105619. PubMed ID: 35690234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutational dynamics across VOCs in International travellers and Community transmission underscores importance of Spike-ACE2 interaction.
    Mehta P; Ravi V; Devi P; Maurya R; Parveen S; Mishra P; Yadav A; Swaminathan A; Saifi S; Khare K; Chattopadhyay P; Yadav M; Chauhan NS; Tarai B; Budhiraja S; Shamim U; Pandey R
    Microbiol Res; 2022 Sep; 262():127099. PubMed ID: 35779308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Spike-Stabilizing D614G Mutation Interacts with S1/S2 Cleavage Site Mutations To Promote the Infectious Potential of SARS-CoV-2 Variants.
    Gellenoncourt S; Saunders N; Robinot R; Auguste L; Rajah MM; Kervevan J; Jeger-Madiot R; Staropoli I; Planchais C; Mouquet H; Buchrieser J; Schwartz O; Chakrabarti LA
    J Virol; 2022 Oct; 96(19):e0130122. PubMed ID: 36121299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hospitalization and Mortality Risk for COVID-19 Cases With SARS-CoV-2 AY.4.2 (VUI-21OCT-01) Compared to Non-AY.4.2 Delta Variant Sublineages.
    Nyberg T; Harman K; Zaidi A; Seaman SR; Andrews N; Nash SG; Charlett A; Lopez Bernal J; Myers R; Groves N; Gallagher E; Gharbia S; Chand M; Thelwall S; De Angelis D; Dabrera G; Presanis AM
    J Infect Dis; 2022 Sep; 226(5):808-811. PubMed ID: 35184201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. No evidence for increased cell entry or antibody evasion by Delta sublineage AY.4.2.
    Arora P; Kempf A; Nehlmeier I; Graichen L; Winkler MS; Lier M; Schulz S; Jäck HM; Pöhlmann S; Hoffmann M
    Cell Mol Immunol; 2022 Mar; 19(3):449-452. PubMed ID: 34983951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SARS-CoV-2 Spatiotemporal Genomic and Molecular Analysis of the First Wave of the COVID-19 Pandemic in Macaé, the Brazilian Capital of Oil.
    da-Costa-Rodrigues B; Cheohen C; Sciammarella F; Pierre-Bonetti-Pozzobon A; Ribeiro L; Nepomuceno-Silva JL; Medeiros M; Mury F; Monteiro-de-Barros C; Lazoski C; Leal-da-Silva M; Tanuri A; Nunes-da-Fonseca R
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The variants question: What is the problem?
    Zella D; Giovanetti M; Benedetti F; Unali F; Spoto S; Guarino M; Angeletti S; Ciccozzi M
    J Med Virol; 2021 Dec; 93(12):6479-6485. PubMed ID: 34255352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genomics of postvaccination SARS-CoV-2 infections during the Delta dominated second wave of COVID-19 pandemic, from Mumbai Metropolitan Region (MMR), India.
    Nilgiriwala K; Kadam P; Patel G; Shaikh A; Mestry T; Vaswani S; Sakthivel S; Poojary A; Gandhi B; Rohra S; Udwadia Z; Oswal V; Shah D; Gomare M; Sriraman K; Mistry N
    J Med Virol; 2022 Sep; 94(9):4206-4215. PubMed ID: 35578378
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evolution of SARS-CoV-2 Envelope, Membrane, Nucleocapsid, and Spike Structural Proteins from the Beginning of the Pandemic to September 2020: A Global and Regional Approach by Epidemiological Week.
    Troyano-Hernáez P; Reinosa R; Holguín Á
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33557213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comprehensive analysis of clinical indications and viral strain variants among patients infected with SARS-CoV-2 in Inner Mongolia, China.
    Wang B; Li X; Xiao W; Zhang J; Ding H
    Virus Genes; 2023 Jun; 59(3):391-398. PubMed ID: 36905534
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genomic surveillance of the Lambda SARS-CoV-2 variant in a global phylogenetic context.
    Mestanza O; Lizarraga W; Padilla-Rojas C; Jimenez-Vasquez V; Hurtado V; Molina IS; Barcena L; Acedo S; Nuñez A; Gordillo S; Sevilla N; Medrano P; Bailon H; Cáceres O; Galarza M; Rojas-Serrano N; Vargas-Herrera N; Lope-Pari P; Huayra J; Araujo-Castillo RV; Solari L
    J Med Virol; 2022 Oct; 94(10):4689-4695. PubMed ID: 35644902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.